US OptionsDetailed Quotes
HIMS250502C46500
- 0.06
- 0.000.00%
15min DelayClose May 2 16:00 ET
0.00High0.00Low
0.00Open0.06Pre Close0 Volume20 Open Interest46.50Strike Price0.00Turnover2915.74%IV11.17%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type0.0461Delta0.0297Gamma698.00Leverage Ratio-53.8193Theta0.0000Rho32.17Eff Leverage0.0001Vega
Hims & Hers Health Stock Discussion
Gapping Up
$SolarEdge Technologies (SEDG.US)$ surged 12.9% after the smart energy technology company reported a smaller-than-expected loss and higher revenue, along with providing a positive revenue outlook for the second quarter.
$Pony AI (PONY.US)$ shares climbed 9.5% after the company announced a partnership with Uber to deploy its robotaxis on the Uber platform.
Gapping Down
$Palantir (PLTR.US)$ shares dropped 8...
hope we don't drop too much today, still holding some
The stock market ended the session in the red with S&P 500 snapping its nine-session winning streak, closing 0.6% lower. Despite an attempt to move into positive territory, the index fell as much as 0.9% during the session.
Following a robust rally from April lows, the decline is not a surprise but rather a natural pullback. S&...
Hims & Hers Health reported exceptional Q1 2025 financial results with revenue soaring 111% to $586.0 million, compared to $278.2 million in Q1 2024. Online revenue grew 115% to $576.4 million, primarily driven by weight loss solutions including GLP-1 offerings which generated approximately $230 million. The company achieved net income of $49.5 million and Adjusted EBITDA of $91.1 million, with gross margin at 73%.
$Novo-Nordisk A/S (NVO.US)$
No comment yet